J Rich - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

J Rich

Showing results (411-420 of 416) with videos related to

Pageof 42

Sort By:

You have reached the last page of results.This site can display upto 416 results.

Plos Medicine|January 12, 2024

The forecasted prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030: A modeling studyKeri N Althoff, Cameron Stewart, Elizabeth Humes, et al.

Journal of Medicinal Chemistry|August 13, 2021

Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2Tom D Heightman, Valerio Berdini, Luke Bevan, et al.

Journal of Medicinal Chemistry|May 19, 2018

Fragment-Based Discovery of a Potent, Orally Bioavailable Inhibitor That Modulates the Phosphorylation and Catalytic Activity of ERK1/2Tom D Heightman, Valerio Berdini, Hannah Braithwaite, et al.

Nature|October 7, 2005

The afterglow of GRB 050709 and the nature of the short-hard gamma-ray burstsD B Fox, D A Frail, P A Price, et al.

Journal of Medicinal Chemistry|May 8, 2025

Correction to "Fragment-Based Discovery of Allosteric Inhibitors of SH2 Domain-Containing Protein Tyrosine Phosphatase-2 (SHP2)"James E H Day, Valerio Berdini, Joan Castro, et al.

Journal of Medicinal Chemistry|March 11, 2024

Fragment-Based Discovery of Allosteric Inhibitors of SH2 Domain-Containing Protein Tyrosine Phosphatase-2 (SHP2)James E H Day, Valerio Berdini, Joan Castro, et al.

Pageof 42

Search research articles

Showing results (411-420 of 416) with videos related to

Sort By:

Pageof 42

You have reached the last page of results.This site can display upto 416 results.

Plos Medicine|January 12, 2024

The forecasted prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030: A modeling studyKeri N Althoff, Cameron Stewart, Elizabeth Humes, et al.

Journal of Medicinal Chemistry|August 13, 2021

Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2Tom D Heightman, Valerio Berdini, Luke Bevan, et al.

Journal of Medicinal Chemistry|May 19, 2018

Fragment-Based Discovery of a Potent, Orally Bioavailable Inhibitor That Modulates the Phosphorylation and Catalytic Activity of ERK1/2Tom D Heightman, Valerio Berdini, Hannah Braithwaite, et al.

Nature|October 7, 2005

The afterglow of GRB 050709 and the nature of the short-hard gamma-ray burstsD B Fox, D A Frail, P A Price, et al.

Journal of Medicinal Chemistry|May 8, 2025

Correction to "Fragment-Based Discovery of Allosteric Inhibitors of SH2 Domain-Containing Protein Tyrosine Phosphatase-2 (SHP2)"James E H Day, Valerio Berdini, Joan Castro, et al.

Journal of Medicinal Chemistry|March 11, 2024

Fragment-Based Discovery of Allosteric Inhibitors of SH2 Domain-Containing Protein Tyrosine Phosphatase-2 (SHP2)James E H Day, Valerio Berdini, Joan Castro, et al.

Pageof 42